About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Genetic Risk Assessment of Defibrillator Events

Genetic Risk Assessment of Defibrillator Events

NCT02045043·6 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Iowa

With

National Heart, Lung, and Blood Institute (NHLBI)

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

An ICD placed during the last 5 years, or a planned ICD within 1 month
Age 18 or older
Left Ventricular Ejection fraction \< or = 30%
Ability to give informed consent

You may not be if

Patient refuses or is unable to give consent
A life expectancy \<6 months from a non-cardiac life threatening disease
Ongoing Class IV heart failure symptoms despite treatment
History of cardiac transplant or left ventricular assist device

The record

StatusCompleted

PhaseNo phase

Taking part1,807

StartedMar 2002

UpdatedJan 24, 2014

Conditions

Sudden Cardiac Death Arrhythmias Congestive Heart Failure Cardiomyopathy

Where6

Emory University
Atlanta, Georgia, United States
Massuchetts General Hospital
Boston, Massachusetts, United States
The Ohio State University
Columbus, Ohio, United States